David Y. Léger
- Molecular Biology top 10%
- Biomedical Engineering top 10%
- Biomaterials top 5%
- Pulmonary and Respiratory Medicine top 10%
- Materials Chemistry
- Co-authors
- Bertrand LiagreJean‐Louis BeneytoutVincent SolFrédérique BrégierVincent ChaleixMohamed HmamouchiRobert GranetAline Pinon
- Topics
- Photodynamic Therapy Research Studies (14 papers)Nanoplatforms for cancer theranostics (12 papers)Phytochemical Studies and Bioactivities (10 papers)
- Partner nations
- FranceLebanonSwitzerland
In The Last Decade
David Y. Léger
57 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 108
- Molecular Biology 748
- Biomedical Engineering 316
- Biomaterials 249
- Pulmonary and Respiratory Medicine 228
- Materials Chemistry 212
Countries citing papers authored by David Y. Léger
This map shows the geographic impact of David Y. Léger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Y. Léger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Y. Léger more than expected).
Fields of papers citing papers by David Y. Léger
This network shows the impact of papers produced by David Y. Léger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Y. Léger. The network helps show where David Y. Léger may publish in the future.
Co-authorship network of co-authors of David Y. Léger
This figure shows the co-authorship network connecting the top 25 collaborators of David Y. Léger. A scholar is included among the top collaborators of David Y. Léger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Y. Léger. David Y. Léger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 15 | |
| 3 | 27 | |
| 4 | 30 | |
| 5 | 40 | |
| 6 | 160 | |
| 7 | 17 | |
| 8 | 24 | |
| 9 | 15 | |
| 10 | 104 | |
| 11 | 61 | |
| 12 | 44 | |
| 13 | 112 | |
| 14 | 50 | |
| 15 | 95 | |
| 16 | 18 | |
| 17 | 25 | |
| 18 | 20 | |
| 19 | 25 | |
| 20 | 47 |
About David Y. Léger
David Y. Léger is a scholar working on Toxicology, Pharmacology and Applied Microbiology and Biotechnology, having authored 57 papers that have together received 1.8k indexed citations. Recurring topics across this work include Photodynamic Therapy Research Studies (14 papers), Nanoplatforms for cancer theranostics (12 papers) and Phytochemical Studies and Bioactivities (10 papers). The work is most often cited by research in Biomaterials (249 citations), Toxicology (65 citations) and Molecular Medicine (78 citations). David Y. Léger has collaborated with scholars based in France, Lebanon and Switzerland. Frequent co-authors include Bertrand Liagre, Jean‐Louis Beneytout, Vincent Sol, Frédérique Brégier, Vincent Chaleix, Mohamed Hmamouchi, Robert Granet, Aline Pinon, Bruno Therrien and Youness Limami. Their work appears in journals such as Journal of the American Chemical Society, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.